TMPRSS2 and prostate cancer: It is important to note that prostate cancer exhibiting PTEN loss concomitantly displays TMPRSS2-ERG fusion; in contrast, not all of the TMPSS2-ERG fusion-positive tumors show PTEN deletion [119].